Similar articles for PMID: 23990055

Year	Number of Results
1927	1
1996	3
1997	1
1998	1
1999	4
2000	4
2001	8
2002	4
2003	10
2004	7
2005	7
2006	8
2007	15
2008	11
2009	20
2010	13
2011	20
2012	22
2013	21
2014	27
2015	30
2016	37
2017	32
2018	24
2019	25
2020	19
2021	22
2022	9
2023	8
2024	0

1

Immunization with an HPV-16 L1-based chimeric virus-like particle containing HPV-16 E6 and E7 epitopes elicits long-lasting prophylactic and therapeutic efficacy in an HPV-16 tumor mice model.

Monroy-García A, Gómez-Lim MA, Weiss-Steider B, Hernández-Montes J, Huerta-Yepez S, Rangel-Santiago JF, Santiago-Osorio E, Mora García Mde L. Monroy-García A, et al. Arch Virol. 2014 Feb;159(2):291-305. doi: 10.1007/s00705-013-1819-z. Epub 2013 Aug 29. Arch Virol. 2014. PMID: 23990055

2

An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice.

Paz De la Rosa G, Monroy-García A, Mora-García Mde L, Peña CG, Hernández-Montes J, Weiss-Steider B, Gómez-Lim MA. Paz De la Rosa G, et al. Virol J. 2009 Jan 6;6:2. doi: 10.1186/1743-422X-6-2. Virol J. 2009. PMID: 19126233 Free PMC article.

3

Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.

Boxus M, Fochesato M, Miseur A, Mertens E, Dendouga N, Brendle S, Balogh KK, Christensen ND, Giannini SL. Boxus M, et al. J Virol. 2016 Jun 24;90(14):6314-25. doi: 10.1128/JVI.00449-16. Print 2016 Jul 15. J Virol. 2016. PMID: 27147749 Free PMC article.

4

Human papillomavirus 16 L1-E7 chimeric virus like particles show prophylactic and therapeutic efficacy in murine model of cervical cancer.

Sharma C, Dey B, Wahiduzzaman M, Singh N. Sharma C, et al. Vaccine. 2012 Aug 3;30(36):5417-24. doi: 10.1016/j.vaccine.2012.06.010. Epub 2012 Jun 17. Vaccine. 2012. PMID: 22717329

5

A novel HPV 16 L1-based chimeric virus-like particle containing E6 and E7 seroreactive epitopes permits highly specific detection of antibodies in patients with CIN 1 and HPV-16 infection.

Monroy-García A, Gómez-Lim MA, Weiss-Steider B, la Rosa GP, Hernández-Montes J, Pérez-Saldaña K, Tapia-Guerrero YS, Toledo-Guzmán ME, Santiago-Osorio E, Sanchez-Peña HI, Mora-García Mde L. Monroy-García A, et al. Virol J. 2011 Feb 9;8:59. doi: 10.1186/1743-422X-8-59. Virol J. 2011. PMID: 21306638 Free PMC article.

6

Human papillomavirus L1 protein expressed in Escherichia coli self-assembles into virus-like particles that are highly immunogenic.

Chen Y, Liu Y, Zhang G, Wang A, Dong Z, Qi Y, Wang J, Zhao B, Li N, Jiang M. Chen Y, et al. Virus Res. 2016 Jul 15;220:97-103. doi: 10.1016/j.virusres.2016.04.017. Epub 2016 Apr 20. Virus Res. 2016. PMID: 27107614

7

Efficacy of DNA vaccines forming e7 recombinant retroviral virus-like particles for the treatment of human papillomavirus-induced cancers.

Lescaille G, Pitoiset F, Macedo R, Baillou C, Huret C, Klatzmann D, Tartour E, Lemoine FM, Bellier B. Lescaille G, et al. Hum Gene Ther. 2013 May;24(5):533-44. doi: 10.1089/hum.2012.037. Epub 2013 May 6. Hum Gene Ther. 2013. PMID: 23521528

8

Combined prophylactic and therapeutic intranasal vaccination against human papillomavirus type-16 using different adeno-associated virus serotype vectors.

Nieto K, Kern A, Leuchs B, Gissmann L, Müller M, Kleinschmidt JA. Nieto K, et al. Antivir Ther. 2009;14(8):1125-37. doi: 10.3851/IMP1469. Antivir Ther. 2009. PMID: 20032542

9

Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.

Peng S, Ferrall L, Gaillard S, Wang C, Chi WY, Huang CH, Roden RBS, Wu TC, Chang YN, Hung CF. Peng S, et al. mBio. 2021 Jan 19;12(1):e03224-20. doi: 10.1128/mBio.03224-20. mBio. 2021. PMID: 33468698 Free PMC article.

10

Activation of dendritic cells and induction of T cell responses by HPV 16 L1/E7 chimeric virus-like particles are enhanced by CpG ODN or sorbitol.

Freyschmidt EJ, Alonso A, Hartmann G, Gissmann L. Freyschmidt EJ, et al. Antivir Ther. 2004 Aug;9(4):479-89. Antivir Ther. 2004. PMID: 15456078

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

371 results

Results by year